Analysis Topic: Companies Analysis
The analysis published under this topic are as follows.
Friday, October 08, 2021
How to handle the “Twin Crises” Evergrande and Debt Ceiling Threatening Stocks / Companies / Tech Stocks
By: Stephen_McBride
It’s the most overused word in finance…And right now, markets are being tested by two “crises” at once.
You’ve likely noticed these “crises” are dragging down stocks, especially tech stocks. The Nasdaq just had its worst day since March. It’s now lost 6% in the last two weeks.
A 6% dip might not sound all that big… and it’s not. It’s a perfectly normal gyration that happens a few times a year.
But this dip feels worse to many folks, since it’s the first meaningful drop in the Nasdaq since May.
Today, we’ll look at the “twin crises” the media is focused on. And we’ll evaluate if and where you should shift your money in response to them…
Read full article... Read full article...
Wednesday, October 06, 2021
CISCO 2020 Dot com Bubble Stock vs 2021 Bubble Tech Stocks Warning Analysis / Companies / Tech Stocks
By: Nadeem_Walayat
CISCO, the backbone of the then fast developing internet, much as Tesla is the backbone of the fast emerging EV and automated vehicles sector, with the likes of Google throwing tens of billions into AI and robotics each year. Everyone owned Cisco, just as everyone owns Google, Amazon, Apple or Facebook stock today.
Back In March 2000 Cisco was trading at a price of $146, on a PE of 120, to the moon, TO THE MOON! Where many were concerned Cisco WAS the Internet, one of the most valuable certification tracks of the time were those by Cisco, where even I was CCNA certified, desperately trying not to get further sucked into the highly costly Cisco certification tracks where CCNA gave way to CCNP to CCIE and beyond, the certifications were mushrooming into more OTT levels than what scientology has! CCNA OTTIV where after decades and several hundreds of thousands of dollars one would become one with the internet, be able to move data packets around with their mind! Other companies soon saw what a money spinner the certification tracks were and so the likes of Microsoft started their own such as Microsoft Office certifications, but I digress.
Read full article... Read full article...
Wednesday, October 06, 2021
FB, AMZN, NFLX, GOOG, AAPL and FANG+ '5 Waves' Speaks Volumes / Companies / Tech Stocks
By: EWI
Hi Reader,
On the heels of Facebook's 5% sell-off, it's worth talking about the rest of the FAANGs -- the tech heavyweights: Apple (AAPL), Amazon (AMZN), Netflix (NFLX); and Alphabet (GOOG).
Our friends at the world's largest market-forecasting firm Elliott Wave International tell us that for the past couple of weeks, something's been happening in the FANG+ index that deserves your attention.
Read full article... Read full article...
Monday, October 04, 2021
Chasing Value with Five More Biotech Stocks for the Long-run / Companies / BioTech
By: Nadeem_Walayat
Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.
1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.
2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.
Read full article... Read full article...
Sunday, October 03, 2021
Aptorum Group - APM - High RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run / Companies / BioTech
By: Nadeem_Walayat
Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.
1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.
2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.
3. That one of my former biotech 12xers got taken over (GW Pharma) that flooded my account with cash early May and so that focused my attention on repopulating my portfolio with 10 more biotech stocks where I expect at least 3 to 10x, with most of the rest expected to survive to varying extent. Though this is the stock market and so there are never any guarantees especially where such smallish cap stocks are concerned.
Read full article... Read full article...
Friday, October 01, 2021
Microsoft Stock Valuation 2021 vs 2000 Bubble - Buy Sell or Hold Invest Analysis / Companies / Microsoft
By: Nadeem_Walayat
Microsoft's stock price in March 2000 was trading at $120 on a earnings multiple of 56 as the stock was in a race to become the worlds first $1 trillion market cap stock. Set this against today's price of $289 and multiple of 36, coupled with an EC score of 71.
This video is an excerpt form my recent in-depth analysis evaluates the current state of the tech stocks bubble of 2021 in comparison to 2000. AI Stocks Portfolio Buying and Selling Levels, Bubble Valuations 2000 vs 2021
Read full article... Read full article...
Friday, October 01, 2021
How to profit off the Acquisition spree in Fintech Stocks / Companies / Fin Tech
By: Stephen_McBride
By Justin Spittler: A buying frenzy is underway on a stock not many investors have heard about…
Even fewer have positioned themselves to cash in on it.
But RiskHedge subscribers have been making a killing off this buying frenzy.
I’m talking about returns of 47% and 35% in a single day.
In a minute, I’ll share the name of the stock that’s delivering these fat returns. And how you should play it to take advantage.
But let’s start by looking at what’s unfolding…
Thursday, September 30, 2021
BioDelivery Sciences International - BDSI - High RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run / Companies / BioTech
By: Nadeem_Walayat
Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.
1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.
2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.
3. That one of my former biotech 12xers got taken over (GW Pharma) that flooded my account with cash early May and so that focused my attention on repopulating my portfolio with 10 more biotech stocks where I expect at least 3 to 10x, with most of the rest expected to survive to varying extent. Though this is the stock market and so there are never any guarantees especially where such smallish cap stocks are concerned.
Read full article... Read full article...
Wednesday, September 29, 2021
Takeda - TAK - High RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run / Companies / BioTech
By: Nadeem_Walayat
Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.
1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.
2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.
3. That one of my former biotech 12xers got taken over (GW Pharma) that flooded my account with cash early May and so that focused my attention on repopulating my portfolio with 10 more biotech stocks where I expect at least 3 to 10x, with most of the rest expected to survive to varying extent. Though this is the stock market and so there are never any guarantees especially where such smallish cap stocks are concerned.
Read full article... Read full article...
Tuesday, September 28, 2021
Cara Therapeutics - CARA - High RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run / Companies / BioTech
By: Nadeem_Walayat
Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.
1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.
2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.
3. That one of my former biotech 12xers got taken over (GW Pharma) that flooded my account with cash early May and so that focused my attention on repopulating my portfolio with 10 more biotech stocks where I expect at least 3 to 10x, with most of the rest expected to survive to varying extent. Though this is the stock market and so there are never any guarantees especially where such smallish cap stocks are concerned.
Read full article... Read full article...
Tuesday, September 28, 2021
US Antitrust Against the Big Tech / Companies / Tech Stocks
By: Dan_Steinbock
In the United States, the executive branch, courts and Congress are moving to restrict the dominance of the U.S. tech giants.
In the 1960s, the US economy was driven by the automobile sector’s Big Three: GM, Chrysler and Ford. Today, it is fueled by the Big Tech. Over the past decade, US Big Tech has revolutionized internet economy, but allegedly abused its dominance.
In June 2019, the antitrust enforcers agreed to focus on Google, Apple, Facebook and Amazon, while dividing responsibility over investigations. In October 2020, the House Committee finished a report recommending a range of measures to address the firms’ allegedly anticompetitive conduct. And in June, the Committee ordered to be reported a series of antitrust bills directed at Big Tech.
Last December, the US Federal Trade Commission (FTC), in cooperation with 46 US states, launched an antitrust lawsuit against Facebook regarding its acquisition of two rivals, Instagram and WhatsApp, and the consequent monopoly power.
Monday, September 27, 2021
Blueprint Medicines - BPMC - High RIsk Biotech Stocks Buy, Sell, Hold Investing Analysis for the Long-run / Companies / BioTech
By: Nadeem_Walayat
Five more biotech stocks to add to the strategy of invest and forget for a potential X10 return. a reminder of why I am engaging in this binge on biotech stocks after having been focused on AI stocks for the past 5 years.
1. Biotech stocks are an unloved stocks sector whilst tech stocks over valued, even the ultra safe stocks such as the Top 10, so I am reluctant to add at current valuations hence why I hit the SELL button for the first time in many years and reduced my exposure to AI stocks by about 40%.
2. That biotech is a derivative of AI, we'll most sectors will soon become a derivative of AI because it is the PRIMARY tech megatrend of our age that will continue to broaden its reach to encompass all sectors of the economy.
3. That one of my former biotech 12xers got taken over (GW Pharma) that flooded my account with cash early May and so that focused my attention on repopulating my portfolio with 10 more biotech stocks where I expect at least 3 to 10x, with most of the rest expected to survive to varying extent. Though this is the stock market and so there are never any guarantees especially where such smallish cap stocks are concerned.
Read full article... Read full article...
Saturday, September 18, 2021
Dow Forecasting Neural Nets, Crossing the Rubicon With Three High Risk Chinese Tech Stocks / Companies / Investing 2021
By: Nadeem_Walayat
Dear Reader
This is the concluding 2nd part of my recent extensive analysis (Part 1) focused on my continuing pursuit to gradually off load my stock analysis processing power onto neural nets, where part 2 looks at data preprocessing being critical in arriving at neural networks that output useful predictions as opposed to nonsense.
And then I literally crossed the rubicon in considering investing in three high risk Chinese tek giants given their relatively attractive valuations following their 2021 stock price blood bath in comparison to US tech stocks being driven to bubble mania valuation peaks.
Read full article... Read full article...
Thursday, September 16, 2021
Consistent performance makes waste a good place to buy stocks / Companies / Investing 2021
By: Submissions
Stocks can turn out to be a valuable part of your investment portfolio. Owning shares in different companies can help build savings, stay ahead of inflation, getting a sense of control over your financial future. The key to investing is figuring out how much the industry will grow and affect society. Practically, you have to determine the competitive advantage of any given company and, most importantly, the durability of that advantage. These companies are closely connected to the economy, meaning that their business volume can fall abruptly during recessions. Let’s not forget that the COVID-19 pandemic is pushing the global economy into a recession.
If waste and recycling isn’t among your top picks for buying stocks, it should be. Surging commodity prices provide a significant boost for the largest publicly traded waste and recycling haulers. Trash can turn out to be the perfect place to look for opportunities. Waste management is a capital-intensive, highly regulated, necessary service. And it generates cash flow. From investors to governments and companies, just about everyone these days is concerned about the ever-growing waste problem. The waste and recycling industry is a viable and important investment option.
Wednesday, September 15, 2021
How does product development affect a company’s market value? / Companies / SME
By: Submissions
Any company strives to serve its customers and make itself sustainable to achieve its goals and missions. By launching new products, an organization can meet the seasonal requirements of customers in the market. It’s not viable to remain within the traditional product lines and expect them to sell for years at an end. On the contrary, it’s necessary to introduce new, improved products to enhance efficiency and improve profitability. Innovation is paramount to company success, as customers are becoming more demanding and savvier. Entrepreneurs need an edge to survive and, most importantly, stand out.
If products are more attractive to customers, sales spur and lead to business growth. Product development plays a key role in the growth strategy of a firm. Not surprisingly, it influences the market value of a business. Why does market value matter, anyway? Because it eliminates ambiguity and uncertainty when it comes to determining how much the company is really worth. Market value highlights the value to investors in the marketplace, offering transparency and clarity to share buyers and sellers alike.
Monday, September 13, 2021
6 Tips For Wise Investment / Companies / Investing 2021
By: Mark_Adan
Investing your Money Wisely is solemnly a daunting thing. To commence it smoothly and infinitely a basic and prominent Investing knowledge is essential. In addition, patience, and wise counsel are also required to enhance your investments, thus income becoming more positive.
Assuredly, you might have heard from your close ones about their investments in the stock market that helped them out to earn torn of money, and influenced you too as you thought it look incredible, isn’t it?
But in reality, all the victorious millionaires achieved that position by investing their money wisely for a long period of time.
Most of their strategies can turn out useful to beginners and others. So, here are the tips provided for Wise Investment that is shared by the experienced one.
Wednesday, September 08, 2021
Hyper Growth Stocks - This billionaire is now using one of our top strategies / Companies / Investing 2021
By: Stephen_McBride
By Justin Spittler :
Has billionaire Dan Loeb been reading the RiskHedge Report?
Loeb climbed to the top of Wall Street by achieving remarkable success as an “activist investor.”
In a nutshell, Loeb would buy large stakes in struggling companies… replace management… and make other adjustments (like cutting a dividend) to turn around the company.
That’s how Loeb amassed a $4 billion fortune.
Most people with that much success wouldn’t change their approach. If it isn’t broke, why fix it, right?
But Loeb recently made a huge change in how he invests…
Sunday, September 05, 2021
How the sale of a Sting CD sparked an Entire Online Industry / Companies / Internet
By: Stephen_McBride
On an August afternoon in 1994, 21-year-old Dan Kohn made history.Kohn had just sold a CD to a man in Philadelphia through his clunky website.
The man paid $12.48 plus shipping for a copy of "Ten Summoner’s Tales" by the rock star Sting.
Why was this such a big deal?
Read full article... Read full article...
Sunday, September 05, 2021
Three Years of Fresh Thinking With Scott Dylan and Dave Antrobus / Companies / SME
By: Sumeet_Manhas
Since launching in 2018, the Mancunian capital investment agency Fresh Thinking Group has helped numerous businesses achieve their desired growth.
There are over 500,000 distressed companies in the UK. That’s just one of the reasons why private equity and distressed M&A investor Scott Dylan teamed up with award-winning technology specialist Dave Antrobus to launch Fresh Thinking in 2018. The forward-thinking capital investment group offers the personalised support and funding these distressed companies need to flourish in their markets.
Since kickstarting the group’s plans to help companies in digital and logistics markets transform their business models, the two entrepreneurs have achieved a huge level of success in raising Fresh Thinking’s profile. Here’s how they’ve helped companies across the UK launch, recover, and grow over the past three years.
Saturday, September 04, 2021
The Most Actively Traded Companies on the Toronto Stock Exchange / Companies / Canada
By: Submissions
The Toronto Stock Exchange is a Canadian stock exchange based in Toronto. Based on market capitalization, it's the eighth-largest exchange in the world and the third-largest in North America. A wide range of businesses from Canada and all over the world are listed on the exchange, and along with conventional securities, traders can also access exchange-traded funds, split share corporations and investment funds.
Read full article... Read full article...